-+ 0.00%
-+ 0.00%
-+ 0.00%

ELI LILLY: RETATRUTIDE DELIVERED GREATER IMPROVEMENTS THAN OZEMPIC ACROSS CERTAIN CARDIOVASCULAR RISK FACTORS IN TRIAL

路透·10/28/2026 10:45:00

请登录查看新闻详情